mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.6 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |